Series A · Agritech
Robigo raises Series A for US biopesticide launch efforts
Leaps by Bayer led the undisclosed round, with SVG Thrive, Endeavor8, Congruent Ventures and Illumina Ventures.
Robigo plans to accelerate commercial-launch efforts for engineered microbial biopesticides targeting fungal diseases in US soybeans and specialty crops.
It will also expand the pipeline to additional soil-borne pathogens affecting broadacre crops. Products remain in development as the company advances field and commercialization programs.
Use of funds
Accelerate commercial launch of engineered microbial biopesticides for fungal diseases in U.S. soybeans and specialty crops
Expand pipeline to additional soil-borne pathogens in broadacre crops
Funding history
Series A · This roundUndisclosed